We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| E-therapeutics Plc | ETX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.65 | -6.74% | 9.00 | 16:35:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.50 | 9.00 | 10.20 | 9.00 | 9.65 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 12/4/2024 07:49 by 1347 Yes, good points. I'm not sure why any fund manager would say: I'll invest in a company but only if it's not listed? If you believe the company has serious prospects then what is the downside as an investor/fund manager to it being listed? Seems more to me that existing large shareholders prefer it to be unlisted as then there is less scrutiny. Makes you wonder eh?As for the NASDAQ listing, well the pre-cursor to that is usually an OTC listing, well they had that but then delisted at the end of 27 December 2023. They gave just 4 days notice over the Christmas/New Year period, so if there were many Americans interested in the company and taking a stake then they'll be hacked off I would imagine, as are the UK PIs now. As far as AI is concerned, well I can see the potential and it's a field I've worked in, but there's an awful lot of hype/rubbish being spouted about it at the moment, including by ETX I suspect. Ask yourself this, why have they only ever had a few contracts on the go paying relatively small milestone payments after all these years? Go and look at the last Business Update in January 2024 then look at what's happened since. By the way if you chose to hold then if it's anything like Deepmatter, which I suspect it will be as Griffin was behind both, then as a minority shareholder you are not going to get much, if anything, in the way of updates and so are very likely not going to realise what's going on until it's too late. I got just a few hours notice when they did the placing and consolidation at Deepmatter that wiped all but the biggest shareholders out. Personally after this behaviour I wouldn't touch anything Ali's involved in or Griffin is a large shareholder in with a bargepole, even if they discovered eternal life, but that's just my opinion, others should DYOR as they say. |
Posted at 12/4/2024 07:11 by pireric Very much agree with The Millipede/1347Nice excuse to complain that fund managers don't understand the potential risk reward in companies in this space. Most are serial destructors of shareholder value while management get paid richly. Hence they want to go to the US which seems all too happy to throw cash at ventures in the hope that one in 5/10 turns into a multibagger to justify the other failures. Or just to ride the coattails of US retail investors who are happy to pump and dump whatever the latest theme is If they really cared about investors they would have: 1) bought out the minorities or at least put a tender offer in place 2) evaluated a US listing mechanism while keeping ETX listed in the meantime Instead they are just annoying a large proportion of the retail shareholder base. Question around their fiduciary duty to force a bunch to sell at valuations which they self-believe are too low. Eric (no holding, never have) |
Posted at 11/4/2024 18:20 by takeiteasy Moving to nasdaq saved the day for SLN with a wide variety of knowledgeable biotech start up investors to choose from. MCAP much higher in total now (many shares issued) - last fund raising significantly over subscribed. CEO here used to work at SLN and watches all this and yearns for NASDAQ listing for reaching the same benefits. |
Posted at 11/4/2024 17:18 by the millipede I genuinely think his narrative is misguided. London won’t fund this kind of company - with little revenue and a lot of hope - because we have spent years doing so and not making any money.I have been investing on AIM on and off since 2008. Speculative pharma is the same as speculative oil. Risky and capital intensive. And, over the years, high risk has turned out to mean no reward. Too many con artists, failed ventures, and investors with swingeing capital losses. New York will likely discover the same soon enough IMO. |
Posted at 25/9/2023 13:42 by maccamcd Did you listen in on the investor meet presentation a few months ago?I believe it's been mainly one retail investor who's been selling bits continuously...Annoy |
Posted at 17/7/2021 13:22 by ali47fish has anybody watched tye presentation recently on proactive by the ceo which i thought very professional but very specilised area for a lay investor to understand- perhaps some posters here might have gained some insights |
Posted at 25/2/2021 20:26 by dplewis1 No he's just a wealthy investor |
Posted at 24/11/2020 18:01 by dplewis1 Yes it's a bit of a concern. There's been nothing of substance since the collaboration announcement with Galapagos and that was in June.. for a company whose tech is supposedly in such demand this is a worry as an investor. The share price has held up fairly well but come on Ali.. you know the AIM junkies need their RNS fix! |
Posted at 07/10/2020 18:47 by dplewis1 Just precautionary in case the actual revenues look a bit weak or cash burn has increased. ETX is still a bit of a leap of faith for an investor but there's plenty to like, however no harm in buying back them back cheaper if the market takes fright next week |
Posted at 04/6/2020 18:14 by paulcon1 DP.....I agree but my initial reason for investing was the share price was at 2p, the MKt Value was 6-7 million (approx) and investors were taking advantage of Mr Woodford's misery... At 21.75p (week back) I thought ETX share price was in unchartered waters and needed a contract to justify the share price . Other posters disagreed... It is very difficult to place a price on potential and Intellectual Property.. That said, ETX, look to have great technology that could have game-changing possibilities, have a strong team and some wealthy investors seem to be very keen to hoover up shares. The more I read (and partially understand) the more impressed I am with their work and vision. I bought some shares at 17.25p today... The joys of investing!! GLA and IMHO |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
